Blue Cross Blue Shield · Drg Stimulator · US health-plan appeal rights

Drg Stimulator denied for failing step therapy by Blue Cross Blue Shield?

Q: How long do I have to appeal a Blue Cross Blue Shield Drg Stimulator denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-09

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Blue Cross Blue Shield typically requires

Blue Cross Blue Shield's specific coverage criteria for drg stimulator are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: Anthem clinical guideline (SCS) + the applicable clinical guideline (RFA) + the applicable BCBS policy (SI Joint Fusion) + the applicable BCBS policy (Vertebroplasty)

The Blue Cross Blue Shield angle on Drg Stimulator

## Why BCBS Requires Step Therapy Before a Dorsal Root Ganglion Stimulator — and How to Challenge It

Blue Cross Blue Shield step-therapy (also called "fail-first") denials for dorsal root ganglion (DRG) stimulation systems occur when the plan requires documented failure of one or more specified prior treatments before it will authorize the device. If your claim was denied because BCBS does not see evidence of those prior steps in your records, or believes you skipped a required rung on the treatment ladder, this is the denial you are facing.

### Why This Denial Is Appealable

Step-therapy protocols must still be evaluated against your individual clinical circumstances. Under ERISA §503 and ACA §2719, your plan cannot apply a step-therapy requirement in a way that is arbitrary or that ignores clinical evidence showing the required prior steps are medically contraindicated, already failed, or clinically inappropriate for your specific condition. Many states also have step-therapy override laws that impose additional obligations on the insurer.

### Your Appeal Timeline

Internal appeal: File within the deadline on your denial notice (commonly 180 days for ERISA plans). Standard decisions within 30–60 days; expedited decisions within 72 hours for urgent cases.
External review: After exhausting internal appeals, you generally have approximately four months to request independent external review. Expedited external review is available when your health or ability to regain maximum function is seriously jeopardized by delay.

### Documentation to Gather

1. Diagnosis confirmation — imaging, nerve studies, and chart notes confirming the pain diagnosis and the specific anatomical distribution that makes DRG stimulation appropriate. 2. Prior treatment history with dates and outcomes — a comprehensive, dated log of every treatment the plan's step-therapy policy requires, documenting the dose or intensity used, duration, and why each failed or could not be continued (adverse effects, contraindication, insufficient response). 3. Clinical severity documentation — pain scores, functional status measures, and quality-of-life assessments showing the burden of undertreated pain. 4. Prescriber medical-necessity letter — the implanting physician should address each step-therapy requirement directly: either confirming failure of the required prior treatments or explaining why any un-tried step is medically inappropriate for this patient, citing the FDA-approved labeling for the device. 5. Specialist records — if a pain management specialist or neurologist has evaluated you, include those notes.

### Criteria-Mapping Structure

Obtain the exact text of BCBS's step-therapy criteria for DRG stimulation from the plan's published coverage/medical policy. Map each requirement to your chart:

| Step-Therapy Requirement | Your Evidence | |---|---| | Required prior treatment #1 (per policy) | [Date tried, outcome, why it failed] | | Required prior treatment #2 (per policy) | [Date tried, outcome, or reason clinically inappropriate] | | Qualifying diagnosis | [Chart note reference, imaging date] | | Prescriber specialty requirement | [Implanting physician's credentials] |

Verify the FDA-approved indications for your specific DRG stimulator device, and request BCBS's written coverage policy so your appeal letter addresses every requirement with a corresponding chart fact. If your state has a step-therapy override law, cite it in your appeal.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Blue Cross Blue Shield appeals

Other denial reasons for Blue Cross Blue Shield Drg Stimulator

denied as not medically necessary denied as non-formulary denied for missing prior authorization denied as experimental or investigational denied as not FDA-approved for this use

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-09. Editorial standards: denialhelp.com/authors.